Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspective

Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspective

Richard Macaulay,1 Amit Ahuja,2 Ebenezer Ademisoye,1 Ariadna Juarez-Garcia,3 James W Shaw4 1PAREXEL Access Consulting, London, UK; 2PAREXEL Access Consulting, Union Territory of Chandigarh, India; 3Bristol-Myers Squibb, Mexico City, Mexico; 4Bristol-Myers Squibb, Princeton, NJ, USA Objectives: The i...

Full description

Bibliographic Details
Main Authors: Macaulay R, Ahuja A, Ademisoye E, Juarez-Garcia A, Shaw JW
Format: Article
Language:English
Published: Dove Medical Press 2019-03-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
value framework
value assessment
immuno-oncology
cost-value analysis
Online Access:https://www.dovepress.com/relative-value-assessment-characterizing-the-benefit-of-oncology-thera-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/relative-value-assessment-characterizing-the-benefit-of-oncology-thera-peer-reviewed-article-CEOR

Similar Items